These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 31863416

  • 21. The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I).
    Faries MB, Thompson JF, Cochran A, Elashoff R, Glass EC, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Wang HJ, Morton DL, MSLT Cooperative Group.
    Ann Surg Oncol; 2010 Dec; 17(12):3324-9. PubMed ID: 20614193
    [Abstract] [Full Text] [Related]

  • 22. Impact of extra-nodal extension and AJCC lymph node staging in predicting recurrence following lymphadenectomy in patients with melanoma.
    Downey J, Hamm J, Baliski C.
    Am J Surg; 2024 May; 231():120-124. PubMed ID: 38320886
    [Abstract] [Full Text] [Related]

  • 23. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.
    Wong SL, Morton DL, Thompson JF, Gershenwald JE, Leong SP, Reintgen DS, Gutman H, Sabel MS, Carlson GW, McMasters KM, Tyler DS, Goydos JS, Eggermont AM, Nieweg OE, Cosimi AB, Riker AI, G Coit D.
    Ann Surg Oncol; 2006 Jun; 13(6):809-16. PubMed ID: 16604476
    [Abstract] [Full Text] [Related]

  • 24. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse.
    Govindarajan A, Ghazarian DM, McCready DR, Leong WL.
    Ann Surg Oncol; 2007 Feb; 14(2):906-12. PubMed ID: 17136471
    [Abstract] [Full Text] [Related]

  • 25. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
    Rutkowski P, Szydłowski K, Nowecki ZI, Sałamacha M, Goryń T, Mitręga-Korab B, Pieńkowski A, Dziewirski W, Zdzienicki M.
    World J Surg Oncol; 2015 Oct 13; 13():299. PubMed ID: 26462471
    [Abstract] [Full Text] [Related]

  • 26. Completion lymphadenectomy for a positive sentinel node biopsy in melanoma patients is not associated with a survival benefit.
    Klemen ND, Han G, Leong SP, Kashani-Sabet M, Vetto J, White R, Schneebaum S, Pockaj B, Mozzillo N, Charney K, Hoekstra H, Sondak VK, Messina JL, Zager JS, Han D.
    J Surg Oncol; 2019 Jun 13; 119(8):1053-1059. PubMed ID: 30883771
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Nodal Recurrence is a Primary Driver of Early Relapse for Patients with Sentinel Lymph Node-Positive Melanoma in the Modern Therapeutic Era.
    Mitra D, Ologun G, Keung EZ, Goepfert RP, Amaria RN, Ross MI, Gershenwald JE, Lucci A, Fisher SB, Davies MA, Lee JE, Bishop AJ, Farooqi AS, Wargo J, Guadagnolo BA.
    Ann Surg Oncol; 2021 Jul 13; 28(7):3480-3489. PubMed ID: 33856603
    [Abstract] [Full Text] [Related]

  • 31. Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma.
    Masoud SJ, Perone JA, Farrow NE, Mosca PJ, Tyler DS, Beasley GM.
    Curr Treat Options Oncol; 2018 Sep 19; 19(11):55. PubMed ID: 30232648
    [Abstract] [Full Text] [Related]

  • 32. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
    Lee DY, Lau BJ, Huynh KT, Flaherty DC, Lee JH, Stern SL, O'Day SJ, Foshag LJ, Faries MB.
    J Am Coll Surg; 2016 Jul 19; 223(1):9-18. PubMed ID: 27236435
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Molecular Staging of Sentinel Lymph Nodes Identifies Melanoma Patients at Increased Risk of Nodal Recurrence.
    Kimbrough CW, Egger ME, McMasters KM, Stromberg AJ, Martin RC, Philips P, Scoggins CR.
    J Am Coll Surg; 2016 Apr 19; 222(4):357-63. PubMed ID: 26875070
    [Abstract] [Full Text] [Related]

  • 35. Regional nodal basin control is not compromised by previous sentinel lymph node biopsy in patients with melanoma.
    Gershenwald JE, Berman RS, Porter G, Mansfield PF, Lee JE, Ross MI.
    Ann Surg Oncol; 2000 Apr 19; 7(3):226-31. PubMed ID: 10791854
    [Abstract] [Full Text] [Related]

  • 36. Status of the Regional Nodal Basin Remains Highly Prognostic in Melanoma Patients with In-Transit Disease.
    Gonzalez AB, Jakub JW, Harmsen WS, Suman VJ, Markovic SN.
    J Am Coll Surg; 2016 Jul 19; 223(1):77-85.e1. PubMed ID: 27118347
    [Abstract] [Full Text] [Related]

  • 37. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
    Roka F, Mastan P, Binder M, Okamoto I, Mittlboeck M, Horvat R, Pehamberger H, Diem E.
    Eur J Surg Oncol; 2008 Jan 19; 34(1):82-8. PubMed ID: 17360144
    [Abstract] [Full Text] [Related]

  • 38. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI, Rutkowski P, Kulik J, Siedlecki JA, Ruka W.
    Br J Dermatol; 2008 Sep 19; 159(3):597-605. PubMed ID: 18616789
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.